Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 272

Results For "CRO"

4387 News Found

Nikon India forays into the Indian healthcare sector
News | November 15, 2022

Nikon India forays into the Indian healthcare sector

Nikon’s newly launched product AXR Point scanning confocal microscope provides “World’s largest Field of View” of 25mm in one single shot


SMS Pharma revenue down 9%
News | November 15, 2022

SMS Pharma revenue down 9%

Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market


IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr
News | November 15, 2022

IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr

The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA


Strong order book in CMO segments for J.B. Chemicals & Pharmaceuticals, says Prabhudas Lilladher
News | November 15, 2022

Strong order book in CMO segments for J.B. Chemicals & Pharmaceuticals, says Prabhudas Lilladher

The company sees the business reaching $100mn


Suven Life Sciences posts Q2FY23 consolidated loss at Rs. 23.18 Cr
News | November 14, 2022

Suven Life Sciences posts Q2FY23 consolidated loss at Rs. 23.18 Cr

The company has reported total income of Rs. 4.59 crores during the period ended September 30, 2022


Supriya Lifescience Q2 FY2023 profit slips to Rs. 16.86 Cr
News | November 14, 2022

Supriya Lifescience Q2 FY2023 profit slips to Rs. 16.86 Cr

The company has reported total income of Rs. 114.77 crores during the period ended September 30, 2022.


Aurobindo Pharma Q2 FY23 revenue down 3.4%
News | November 14, 2022

Aurobindo Pharma Q2 FY23 revenue down 3.4%

Formulation revenue decreased by 7.6% YoY to Rs. 4,770 crore whereas in Q2 FY23, API business posted a growth of 24.2% YoY with revenue of Rs. 969.4 crore


Chemcon Q2 FY23 revenue down 5.4%; Profit down 46.6%
News | November 14, 2022

Chemcon Q2 FY23 revenue down 5.4%; Profit down 46.6%

Q2 FY23 business performance has been slow primarily due to lower volume offtake from pharmaceutical manufacturers


Biocon Biologics features on ASIA IP ELITE List 2022
News | November 14, 2022

Biocon Biologics features on ASIA IP ELITE List 2022

This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list